Sexual healthcare is evolving from a reactive model to a proactive one. Traditionally, many people only sought testing or treatment after symptoms appeared or after learning of a potential exposure. Today, prevention-focused care is becoming the gold standard, with regular screening, risk assessment, and preventive treatments helping patients stay ahead of sexually transmitted infections (STIs). At Northwell Medical, we believe that proactive testing combined with evidence-based prevention strategies offers the most effective way to protect sexual health and reduce the spread of common bacterial STIs.
One of the more significant advances in STI prevention recently is Doxycycline Post-Exposure Prophylaxis (Doxy-PEP or DPEP). This approach involves taking a prescribed dose of doxycycline (an antibiotic) shortly after condomless sexual contact to reduce the likelihood of developing certain bacterial STIs. Clinical studies have demonstrated substantial reductions in syphilis and chlamydia infections among individuals using Doxy-PEP, with some research showing reductions of more than 70% for syphilis and chlamydia. For individuals at higher risk of recurrent bacterial STIs, Doxy-PEP represents a powerful new tool that complements routine testing, safer sex practices, and ongoing sexual health monitoring.
The future of sexual healthcare is prevention. Regular STI screening allows infections to be identified and treated early, often before symptoms develop, while preventive strategies such as Doxy-PEP can help stop infections before they occur.
At Northwell Medical, we provide confidential STI testing, personalised risk assessments, and guidance on whether Doxy-PEP may be appropriate for you. By combining regular testing with modern prevention strategies, patients can take greater control of their sexual health and make informed decisions with confidence.